EX-23.1 6 exhibit_231.htm EXHIBIT 23.1_CONSENT exhibit_231.htm
 
EXHIBIT 23.1

Consent of Independent Registered Public Accounting Firm

The Board of Directors
Cytori Therapeutics, Inc.:
 
We consent to the incorporation by reference in the registration statement (Nos. 333-82074 and 333-122691) on Form S-8 and (Nos. 333-140875 and 333-134129) on Form S-3 of Cytori Therapeutics, Inc. of our reports dated of March 13, 2008, with respect to the consolidated balance sheets of Cytori Therapeutics, Inc. and subsidiaries as of December 31, 2007 and 2006, and the related consolidated statements of operations and comprehensive loss, stockholders' equity (deficit), and cash flows for each of the years in the three-year period ended December 31, 2007, the accompanying schedule of valuation and qualifying accounts, and the effectiveness of internal controls over financial reporting of Cytori Therapeutics, Inc. and subsidiaries as of December 31, 2007, and to the reference to our firm in Item 6, Selected Financial Data, which reports appear in the December 31, 2007, annual report on form 10-K of Cytori Therapeutics, Inc.

 
/s/ KPMG LLP
  
 
San Diego, California
March 13, 2008